Open AccessPROSPECTS OF THE USE OF PHOSPHAZIDE IN THE SCHEDULES OF ANTIRETROVIRAL THERAPY FOR HIV INFECTION
Author(s) -
N. N. Vorobiova,
Е. С. Иванова
Publication year - 2013
Publication title -
èpidemiologiâ i infekcionnye bolezni
Language(s) - English
Resource type - Journals
eISSN - 2411-3026
pISSN - 1560-9529
DOI - 10.17816/eid40772
Subject(s) - antiretroviral therapy , medicine , viral load , human immunodeficiency virus (hiv) , antiretroviral agents , disease , immunology , virology
The aim of the study was to evaluate the effectiveness of triple antiretroviral theтру, including domestic product Phosphazide in 18 HIV-infected patients during 48 weeks. There was determined the dynamics of the clinical manifestations of the disease, the parameters of viral load and CD4 lymphocytes before antiretroviral therapy (ART), and 4, 12, 24, 36 and 48 weeks after its use. The study showed high virological and sufficient immunologic efficacy of this schedule.